Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO-Friends of Cancer Research Joint Research Statement.
Edward S KimThomas S UldrickCaroline SchenkelSuanna Steeby BruinoogeRobert Donald HarveyAllison MagnusonAlexander SpiraJames L WadeMark D StewartDiana Merino VegaJulia A BeaverAndrea M DenicoffGwynn IsonS Percy IvySuzanne GeorgeRaymond P PerezPatricia A SpearsWilliam D TapRichard L SchilskyPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Implementation of the recommendations is intended to result in greater ease of determining patient eligibility. Increased opportunities for patient participation in research will help address longstanding underrepresentation of certain groups in clinical trials and produce evidence that is more informative for a broader patient population. More patients eligible will also likely speed clinical trial accrual.See related commentary by Giantonio, p. 2369.